Life Sciences Odyssey Therapeutics Announces Oversubscribed $168 Million Series B Financing AIT News Desk Oct 17, 2022 Odyssey Therapeutics, Inc., a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, announced a $168…